Published in Oncogene on August 15, 2013
Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation. PLoS Genet (2014) 1.09
Genetic alterations of histone lysine methyltransferases and their significance in breast cancer. Oncotarget (2015) 0.90
High EZH2 Protein Expression Is Associated with Poor Overall Survival in Patients with Luminal A Breast Cancer. J Breast Cancer (2016) 0.89
The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER-positive breast cancers. Mol Carcinog (2014) 0.87
Genotranscriptomic meta-analysis of the Polycomb gene CBX2 in human cancers: initial evidence of an oncogenic role. Br J Cancer (2014) 0.84
Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth. Breast Cancer Res (2014) 0.83
EZH2 overexpression in different immunophenotypes of breast carcinoma and association with clinicopathologic features. Diagn Pathol (2016) 0.81
Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer. Breast Cancer Res (2014) 0.79
ERN1 and ALPK1 inhibit differentiation of bi-potential tumor-initiating cells in human breast cancer. Oncotarget (2016) 0.75
Chromatin Memory in the Development of Human Cancers. Gene Technol (2014) 0.75
The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet (1995) 5.83
Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med (1999) 4.22
Inferring subnetworks from perturbed expression profiles. Bioinformatics (2001) 3.93
Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol (2000) 3.75
Distinct physiological states of Plasmodium falciparum in malaria-infected patients. Nature (2007) 3.69
The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet (1997) 2.28
Hurthle cell carcinoma of the thyroid gland. A tumor of moderate malignancy. Cancer (1986) 2.04
Inferring quantitative models of regulatory networks from expression data. Bioinformatics (2004) 2.01
Skin toxic effects of polyethylene glycol-coated liposomal doxorubicin. Arch Dermatol (2000) 1.98
Determinants of the use of complementary therapies by patients with cancer. J Clin Oncol (2001) 1.69
Ovarian cysts in premenopausal and postmenopausal tamoxifen-treated women with breast cancer. Am J Obstet Gynecol (1996) 1.59
Squamous cell carcinoma of the oral tongue in patients younger than 30 years: clinicopathologic features and outcome. Clin Otolaryngol (2010) 1.57
Breast cancer draining to bilateral axillary sentinel lymph nodes. Surgery (2003) 1.56
Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis. Am J Pathol (2000) 1.52
Metastatic lobular carcinoma of the breast: patterns of spread in the chest, abdomen, and pelvis on CT. AJR Am J Roentgenol (2000) 1.50
A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers. Br J Cancer (2004) 1.41
Inhibition of tumor metastasis by heparanase inhibiting species of heparin. Invasion Metastasis (1995) 1.34
Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age. Cancer (1999) 1.33
Nondiagnostic stereotaxic core breast biopsy: results of rebiopsy. Radiology (1996) 1.30
CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers. Br J Cancer (2001) 1.27
Pseudoangiomatous stromal hyperplasia: mammographic, sonographic, and clinical patterns. Radiology (1996) 1.26
Endoscopic transnasal transsphenoidal microsurgery versus the sublabial approach for the treatment of pituitary tumors: endonasal complications. Laryngoscope (1999) 1.23
Digestion of delta-endotoxin by gut proteases may explain reduced sensitivity of advanced instar larvae of Spodoptera littoralis to CryIC. Insect Biochem Mol Biol (1996) 1.20
The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer. Am J Hum Genet (1999) 1.19
Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril (1996) 1.16
Displacement of carcinomatous epithelium in surgical breast specimens following stereotaxic core biopsy. Am J Clin Pathol (1995) 1.13
Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients. Br J Cancer (2006) 1.12
Small polydispersed circular DNA (spcDNA) in human cells: association with genomic instability. Oncogene (1997) 1.11
Influence of diabetes mellitus and glycaemic control on the characteristics and outcome of common infections. Diabet Med (1996) 1.09
Pathophysiology and fate of hepatocytes in a mouse model of mitochondrial hepatopathies. Gut (2007) 1.09
Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. Blood (1996) 1.08
Pathologic analysis of sentinel lymph nodes in breast carcinoma. Cancer (2000) 1.07
Tumor suppressor p53 regulates heparanase gene expression. Oncogene (2006) 1.07
MR imaging of the breast in patients with occult primary breast carcinoma. Radiology (1997) 1.05
Preimplantation genetic diagnosis for BRCA1/2--a novel clinical experience. Prenat Diagn (2009) 1.05
Wwox inactivation enhances mammary tumorigenesis. Oncogene (2011) 1.04
Molecular properties and involvement of heparanase in cancer progression and mammary gland morphogenesis. J Mammary Gland Biol Neoplasia (2001) 1.04
Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycin. Br J Cancer (1991) 1.02
Safety and efficacy of 188-rhenium-labeled antibody to melanin in patients with metastatic melanoma. J Skin Cancer (2013) 1.02
Primary colorectal sarcoma. A retrospective review and prognostic factor study of 50 consecutive patients. Arch Surg (1990) 1.00
Use of high technology imaging for surveillance of early stage breast cancer. Breast Cancer Res Treat (2011) 1.00
Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling. Oncogene (2011) 1.00
Inflammatory breast carcinoma: mammographic findings. Radiology (1994) 0.99
Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study. Eur J Cancer Clin Oncol (1989) 0.98
Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation. Clin Oncol (R Coll Radiol) (2007) 0.96
Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival. Br J Cancer (2007) 0.95
A deletion/insertion mutation in the BRCA2 gene in a breast cancer family: a possible role of the Alu-polyA tail in the evolution of the deletion. Genes Chromosomes Cancer (2001) 0.95
Very late recurrence of hepatocellular carcinoma after liver transplantation: case report and literature review. Transplant Proc (2006) 0.94
Effect of pH levels in swimming pools on enamel of human teeth. Am J Dent (1988) 0.93
Outcome of oral tongue squamous cell carcinoma in patients with and without known risk factors. Oral Oncol (2010) 0.93
Observer variability and applicability of BI-RADS terminology for breast MR imaging: invasive carcinomas as focal masses. AJR Am J Roentgenol (2001) 0.93
Radiocurability of microscopic disease in childhood rhabdomyosarcoma with radiation doses less than 4,000 cGy. J Clin Oncol (1990) 0.92
Haplotype analysis of BRCA2 8765delAG mutation carriers in French Canadian and Yemenite Jewish hereditary breast cancer families. Hum Hered (2001) 0.91
Interleukin-2 improves tumour response to DNP-modified autologous vaccine for the treatment of metastatic malignant melanoma. Br J Cancer (2004) 0.91
Predictive value of sputum cytology. Thorax (1987) 0.90
Clinical studies of liposome-encapsulated doxorubicin. Acta Oncol (1994) 0.90
Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genes. Am J Hum Genet (1998) 0.90
Autologous cell vaccine as a post operative adjuvant treatment for high-risk melanoma patients (AJCC stages III and IV). The new American Joint Committee on Cancer. Br J Cancer (2002) 0.90
Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in israel. Gynecol Oncol (2003) 0.90
Phosphorylation of a K+ channel alpha subunit modulates the inactivation conferred by a beta subunit. Involvement of cytoskeleton. J Biol Chem (1996) 0.89
Cochlear histopathologic analysis in diabetic rats. Am J Otol (1998) 0.89
The 8765delAG mutation in BRCA2 is common among Jews of Yemenite extraction. Am J Hum Genet (1998) 0.88
Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure. Chest (1992) 0.88
Sonographically guided directional vacuum-assisted breast biopsy: preliminary experience in Venezuela. AJR Am J Roentgenol (2001) 0.87
Histological changes in the cervical lymph nodes after radiotherapy. Oncol Rep (2001) 0.87
Mapping of the entomocidal fragment of Spodoptera-specific Bacillus thuringiensis toxin CryIC. Mol Gen Genet (1996) 0.87
Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriers. Br J Cancer (2008) 0.87
Objective and subjective nasal airflow. Am J Otolaryngol (1997) 0.86
Sulfate moieties in the subendothelial extracellular matrix are involved in basic fibroblast growth factor sequestration, dimerization, and stimulation of cell proliferation. J Biol Chem (1996) 0.86
Transmission of response to trauma? Second-generation Holocaust survivors' reaction to cancer. Am J Psychiatry (2000) 0.86
Bulboventricular foramen resection: hemodynamic and electrophysiologic results. Ann Thorac Surg (2001) 0.86
Evaluation of pectoralis major muscle in patients with posterior breast tumors on breast MR images: early experience. Radiology (2000) 0.85
Cisplatin-induced non-convulsive encephalopathy. Anticancer Drugs (1998) 0.85
Psychological intervention in cancer patients: a randomized study. Gen Hosp Psychiatry (2001) 0.85
Epidemiological aspects of idiopathic peripheral facial palsy. Eur J Epidemiol (1986) 0.85
Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity. J Cell Physiol (1995) 0.85
Anti-estrogen therapy for hereditary hemorrhagic telangiectasia - a long-term clinical trial. Rhinology (2011) 0.84
Regulation of RCK1 currents with a cAMP analog via enhanced protein synthesis and direct channel phosphorylation. J Biol Chem (1995) 0.84
Laser posterior ventriculocordectomy with partial arytenoidectomy for the treatment of bilateral vocal fold immobility. J Laryngol Otol (2003) 0.84
Interleukin-6 secretion in mice is associated with reduced glucose-6-phosphatase and liver glycogen levels. Am J Physiol (1997) 0.83
Carcinoma of the uvula and midline soft palate: indication for neck treatment. Head Neck (1992) 0.82
The Effect of Genetic Counseling on Knowledge and Perceptions Regarding Risks for Breast Cancer. J Genet Couns (1998) 0.82
Holocaust cancer patients: a comparative study. Psychiatry (1993) 0.82
Inactivation of a voltage-dependent K+ channel by beta subunit. Modulation by a phosphorylation-dependent interaction between the distal C terminus of alpha subunit and cytoskeleton. J Biol Chem (1997) 0.82
Noninvasive determination of neonatal hyperbilirubinemia: standardization for variation in skin color. Am J Perinatol (1994) 0.82
Follicular carcinoma of the thyroid. Head Neck (1995) 0.82
Gene number, methylation and biological complexity. Trends Genet (1995) 0.82
Tumor necrosis factor inhibits the transcriptional rate of glucose-6-phosphatase in vivo and in vitro. Metabolism (1997) 0.82
Production and purification of melanoma gp100 antigen and polyclonal antibodies. Protein Expr Purif (2004) 0.82
Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients. J Med Virol (1986) 0.82
Impact of core biopsy on the surgical management of impalpable breast cancer: another look at margins. AJR Am J Roentgenol (1997) 0.82
T1 glottic carcinoma involving the anterior commissure. Eur J Surg Oncol (1994) 0.82
Mediastinal lymph node metastases from gastrointestinal carcinoma. Cancer (1987) 0.81
Use of tranquilizers and sleeping pills among cancer patients is associated with a poorer quality of life. Qual Life Res (2004) 0.81
Spontaneous rupture of lung echinococcal cyst causing anaphylactic shock and respiratory distress syndrome. Thorax (2006) 0.81
Effect of pretransplant hepatitis C virus RNA status on posttransplant outcome. Transplant Proc (2008) 0.81
Liver enzymes elevation after HAART in HIV-HCV co-infection. J Viral Hepat (2005) 0.81
Mammographic findings in men with breast cancer. AJR Am J Roentgenol (1993) 0.81
Polymorphous low-grade adenocarcinoma of the submandibular gland. Otolaryngol Head Neck Surg (2000) 0.81